Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

Driving RNA vaccine innovation through microbiome insights is an emerging frontier that moves beyond pathogen-only thinking and toward vaccines designed ...

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...

Add Yahoo as a preferred source to see more of our stories on Google. Messenger RNA, full name messenger ribonucleic acid, is a molecule in the body that carries instructions to make proteins. “To ...

CAMBRIDGE, MA -- Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies.

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a study presented at the European Oncology meeting. Messenger RNA (mRNA) ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

Explore how Moderna makes money through its mRNA vaccines, government contracts, and partnerships, and how products like its COVID-19 vaccine drive revenue.

A study reveals how two proteins cooperate in a key early step of antiviral detection, as reported by researchers at Science ...